- ►annals.org S Stenman, A Melander, PH Groop, LC Groop - Annals of internal medicine, 1993 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
What Is the Benefit of Increasing the Sulfonylurea Dose? Cited by 60 - Related articles - All 3 versions
E Wåhlin-Boll, G Sartor, A Melander, B … - European Journal of Clinical Pharmacology, 1982 - Springer Summary. Ten Type 2 diabetics were examined du- ring long-term treatment, at two
dosage levels, with chlorpropamide once daily and glipizide tid Drug
concentrations were measured by gas chromatogra- phy and high-pressure ... Cited by 32 - Related articles - All 2 versions
A Jönsson, T Rydberg, G Ekberg, B … - Diabetes Care, 1994 - Am Diabetes Assoc OBJECTIVE--To determine the terminal elimination half-life of glyburide in
non-insulin-dependent diabetes mellitus (NIDDM) subjects after cessation of
long-term treatment. RESEARCH DESIGN AND METHODS--Ten NIDDM patients (5 of ... Cited by 28 - Related articles - BL Direct - All 5 versions
L Groop, PH Groop, S Stenman, C Saloranta, … - Diabetes Care, 1987 - Am Diabetes Assoc Fourteen non-insulin-dependent diabetic (NIDDM) patients continued their
previous medication (7 on glyburide, 7 on glipizide) for 6 mo, after which they
switched to the alternate treatment for another 6 mo. The treatment periods ... Cited by 44 - Related articles - All 4 versions
T Rydberg, A Jönsson, M Røder, A Melander - Diabetes care, 1994 - Am Diabetes Assoc OBJECTIVE--To assess the hypoglycemic effect and the insulin-releasing effect of
the main glyburide (glibenclamide) metabolites 4-trans-hydroxy-glibenclamide
(M1) and 3-cis-hydroxy-glibenclamide (M2) in humans. RESEARCH DESIGN AND ... Cited by 43 - Related articles - BL Direct - All 5 versions
A Jonsson, B Hallengren, T Rydberg, A … - Diabetes Obesity and Metabolism, 2001 - interscience.wiley.com Material and methods Fifty patients with type 2 diabetes on regular Gb therapy
(1.75–14.0 mg daily). Blood samples were taken immediately before and 90 min
after regular Gb intake. A standardized breakfast was served 30 min after ... Cited by 22 - Related articles - BL Direct - All 3 versions
LC Groop, N Barzilai, K Ratheiser, L Luzi, E … - Diabetes Care, 1991 - Am Diabetes Assoc OBJECTIVE: To examine the relationship between plasma glyburide concentrations
(0, 50, 100, 200, 400, and 800 nM) and the insulin response and glucose
metabolism during euglycemic (4.6 +/- 0.1 mM) and hyperglycemic (11.6 +/- ... Cited by 41 - Related articles - All 5 versions
- ►diabetesjournals.org A Melander - Diabetes, 2004 - Am Diabetes Assoc Sulfonylureas and glinides have similar mechanisms of action but differ in
receptor affinity and binding sites and in absorption and elimination rates.
This promotes differences in potency, rate of onset, and duration of ... Cited by 5 - Related articles - BL Direct - All 5 versions
[CITATION] the Glipizide Gastrointestinal Therapeutic System Study Group. Efficacy, safety, and dose- …
